608 related articles for article (PubMed ID: 26332594)
21. Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.
Kim Y; Kim JM; Cho HW; Park HY; Park MH
Hum Genet; 2023 Nov; 142(11):1561-1569. PubMed ID: 37728764
[TBL] [Abstract][Full Text] [Related]
22. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
23. Actionable secondary findings from whole-genome sequencing of 954 East Asians.
Tang CS; Dattani S; So MT; Cherny SS; Tam PKH; Sham PC; Garcia-Barcelo MM
Hum Genet; 2018 Jan; 137(1):31-37. PubMed ID: 29128982
[TBL] [Abstract][Full Text] [Related]
24. 1 in 38 individuals at risk of a dominant medically actionable disease.
Haer-Wigman L; van der Schoot V; Feenstra I; Vulto-van Silfhout AT; Gilissen C; Brunner HG; Vissers LELM; Yntema HG
Eur J Hum Genet; 2019 Feb; 27(2):325-330. PubMed ID: 30291343
[TBL] [Abstract][Full Text] [Related]
25. Critical assessment of secondary findings in genes linked to primary arrhythmia syndromes.
Diebold I; Schön U; Scharf F; Benet-Pagès A; Laner A; Holinski-Feder E; Abicht A
Hum Mutat; 2020 May; 41(5):1025-1032. PubMed ID: 32048431
[TBL] [Abstract][Full Text] [Related]
26. ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden.
Sharo AG; Zou Y; Adhikari AN; Brenner SE
Genome Med; 2023 Jul; 15(1):51. PubMed ID: 37443081
[TBL] [Abstract][Full Text] [Related]
27. Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.
Punj S; Akkari Y; Huang J; Yang F; Creason A; Pak C; Potter A; Dorschner MO; Nickerson DA; Robertson PD; Jarvik GP; Amendola LM; Schleit J; Simpson DK; Rope AF; Reiss J; Kauffman T; Gilmore MJ; Himes P; Wilfond B; Goddard KAB; Richards CS
Am J Hum Genet; 2018 Jun; 102(6):1078-1089. PubMed ID: 29754767
[TBL] [Abstract][Full Text] [Related]
28. Actionable secondary findings in arrhythmogenic right ventricle cardiomyopathy genes: impact and challenge of genetic counseling.
Abicht A; Schön U; Laner A; Holinski-Feder E; Diebold I
Cardiovasc Diagn Ther; 2021 Apr; 11(2):637-649. PubMed ID: 33968641
[TBL] [Abstract][Full Text] [Related]
29. Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.
Jang MA; Lee SH; Kim N; Ki CS
Genet Med; 2015 Dec; 17(12):1007-11. PubMed ID: 25856671
[TBL] [Abstract][Full Text] [Related]
30. Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time.
van Rooij J; Arp P; Broer L; Verlouw J; van Rooij F; Kraaij R; Uitterlinden A; Verkerk AJMH
Genet Med; 2020 Nov; 22(11):1812-1820. PubMed ID: 32665702
[TBL] [Abstract][Full Text] [Related]
31. Genome analysis and knowledge-driven variant interpretation with TGex.
Dahary D; Golan Y; Mazor Y; Zelig O; Barshir R; Twik M; Iny Stein T; Rosner G; Kariv R; Chen F; Zhang Q; Shen Y; Safran M; Lancet D; Fishilevich S
BMC Med Genomics; 2019 Dec; 12(1):200. PubMed ID: 31888639
[TBL] [Abstract][Full Text] [Related]
32. The rate of secondary genomic findings in the Saudi population.
Aloraini T; Alsubaie L; Alasker S; Al Muitiri A; Alswaid A; Eyiad W; Al Mutairi F; Ababneh F; Alfadhel M; Alfares A
Am J Med Genet A; 2022 Jan; 188(1):83-88. PubMed ID: 34515413
[TBL] [Abstract][Full Text] [Related]
33. The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort.
Johnston JJ; Brennan ML; Radenbaugh B; Yoo SJ; Hernandez SM; ; Lewis KL; Katz AE; Manolio TA; Biesecker LG
Genet Med; 2022 Mar; 24(3):736-743. PubMed ID: 34906458
[TBL] [Abstract][Full Text] [Related]
34. Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing.
Bowling KM; Thompson ML; Kelly MA; Scollon S; Slavotinek AM; Powell BC; Kirmse BM; Hendon LG; Brothers KB; Korf BR; Cooper GM; Greally JM; Hurst ACE
Genome Med; 2022 Nov; 14(1):131. PubMed ID: 36414972
[TBL] [Abstract][Full Text] [Related]
35. Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia-associated variants.
Paludan-Müller C; Ahlberg G; Ghouse J; Herfelt C; Svendsen JH; Haunsø S; Kanters JK; Olesen MS
Clin Genet; 2017 Jan; 91(1):63-72. PubMed ID: 27538377
[TBL] [Abstract][Full Text] [Related]
36. The Frequency of Discordant Variant Classification in the Human Gene Mutation Database: A Comparison of the American College of Medical Genetics and Genomics Guidelines and ClinVar.
Park KJ; Lee W; Chun S; Min WK
Lab Med; 2021 May; 52(3):250-259. PubMed ID: 32926152
[TBL] [Abstract][Full Text] [Related]
37. The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.
Kullo IJ; Olson J; Fan X; Jose M; Safarova M; Radecki Breitkopf C; Winkler E; Kochan DC; Snipes S; Pacyna JE; Carney M; Chute CG; Gupta J; Jose S; Venner E; Murugan M; Jiang Y; Zordok M; Farwati M; Philogene M; Smith E; Shaibi GQ; Caraballo P; Freimuth R; Lindor NM; Sharp R; Thibodeau SN
Mayo Clin Proc; 2018 Nov; 93(11):1600-1610. PubMed ID: 30392543
[TBL] [Abstract][Full Text] [Related]
38. Actionable exomic incidental findings in 6503 participants: challenges of variant classification.
Amendola LM; Dorschner MO; Robertson PD; Salama JS; Hart R; Shirts BH; Murray ML; Tokita MJ; Gallego CJ; Kim DS; Bennett JT; Crosslin DR; Ranchalis J; Jones KL; Rosenthal EA; Jarvik ER; Itsara A; Turner EH; Herman DS; Schleit J; Burt A; Jamal SM; Abrudan JL; Johnson AD; Conlin LK; Dulik MC; Santani A; Metterville DR; Kelly M; Foreman AK; Lee K; Taylor KD; Guo X; Crooks K; Kiedrowski LA; Raffel LJ; Gordon O; Machini K; Desnick RJ; Biesecker LG; Lubitz SA; Mulchandani S; Cooper GM; Joffe S; Richards CS; Yang Y; Rotter JI; Rich SS; O'Donnell CJ; Berg JS; Spinner NB; Evans JP; Fullerton SM; Leppig KA; Bennett RL; Bird T; Sybert VP; Grady WM; Tabor HK; Kim JH; Bamshad MJ; Wilfond B; Motulsky AG; Scott CR; Pritchard CC; Walsh TD; Burke W; Raskind WH; Byers P; Hisama FM; Rehm H; Nickerson DA; Jarvik GP
Genome Res; 2015 Mar; 25(3):305-15. PubMed ID: 25637381
[TBL] [Abstract][Full Text] [Related]
39. Actionable Genes, Core Databases, and Locus-Specific Databases.
Pinard A; Miltgen M; Blanchard A; Mathieu H; Desvignes JP; Salgado D; Fabre A; Arnaud P; Barré L; Krahn M; Grandval P; Olschwang S; Zaffran S; Boileau C; Béroud C; Collod-Béroud G
Hum Mutat; 2016 Dec; 37(12):1299-1307. PubMed ID: 27600092
[TBL] [Abstract][Full Text] [Related]
40. Actionable Genotypes and Their Association with Life Span in Iceland.
Jensson BO; Arnadottir GA; Katrinardottir H; Fridriksdottir R; Helgason H; Oddsson A; Sveinbjornsson G; Eggertsson HP; Halldorsson GH; Atlason BA; Jonsson H; Oskarsson GR; Sturluson A; Gudjonsson SA; Thorisson GA; Zink F; Moore KHS; Palsson G; Sigurdsson A; Jonasdottir A; Jonasdottir A; Magnusson MK; Helgadottir A; Steinthorsdottir V; Gudmundsson J; Stacey SN; Hilmarsson R; Olafsson I; Johannsson OT; Arnar DO; Saemundsdottir J; Magnusson OT; Masson G; Halldorsson BV; Helgason A; Stefansson H; Jonsdottir I; Holm H; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Stefansson K; Sulem P
N Engl J Med; 2023 Nov; 389(19):1741-1752. PubMed ID: 37937776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
